In resistant cases, efficacy is measured through various parameters such as progression-free survival (PFS), overall survival (OS), and objective response rates (ORR). Advanced imaging techniques and biomarkers are also utilized to assess the tumor's response to new treatments. Importantly, patient quality of life is increasingly being considered when evaluating treatment efficacy.
